Nalaganje...

One year of complete clinical response in a metastatic breast cancer patient treated with a combination of lapatinib and gemcitabine

The treatment of metastatic breast cancer is challenging. We recently assisted in the development of targeted therapies (in combination with chemotherapy or as monotherapy) that have improved results for selected groups of patients. Lapatinib is a dual tyrosine kinase inhibitor that has shown effica...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Gasent Blesa, J.M., Laforga Canales, J., Candel‡, V. Alberola
Format: Artigo
Jezik:Inglês
Izdano: Multimed Inc. 2010
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2854642/
https://ncbi.nlm.nih.gov/pubmed/20404981
Oznake: Označite
Brez oznak, prvi označite!